{
  "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
  "docSlug": "207557819f8810b573d3e2a3179a9bac",
  "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 55,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "agenda",
  "function": "front_matter",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/3",
  "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
  "deckJsonHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d.json",
  "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.8,
        "x": 0.15,
        "y": 0.0015
      },
      "kind": "list",
      "text": "AstraZeneca ambition in oncology - Pascal Soriot; Key oncology themes at WCLC and ESMO - Susan Galbraith; Dato-DXd – patient selection - Susan Galbraith; Expanding into new frontiers: bladder cancer - Prof. Thomas Powles, Sunil Verma; Q&A session I - Dave Fredrickson; Driving the ADC revolution - Matt Hellmann; Leading in next-generation IO - Cristian Massacesi; Closing remarks & Q&A session II - Dave Fredrickson",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbc01acb-b041-4e1b-b0f6-e139178ad8a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.04,
        "y": 0.0019
      },
      "kind": "title",
      "text": "Agenda",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "525b793c-f7ef-4f69-8535-b1ad89ae7829",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.5,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "AstraZeneca @ WCLC and ESMO 2024",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc7b8b9e-9fe6-4978-9743-944097a39e5d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "a160b0cc-add5-4053-9520-00cbc9d764f2",
      "evidence": "list/bullet: AstraZeneca ambition in oncology - Pascal Soriot; Key oncology themes at WCLC and ESMO - Susan Galbraith; Dato-DXd – patient selection - Susan Galbraith; Expanding into new frontiers: bladder cancer - Prof.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}